Published in Lancet on May 24, 1997
Examination of a Soy-Based Supplement for Major Depression | NCT00042380
Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95
Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 8.16
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet (2009) 6.93
The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature (2005) 5.71
Tobacco use among youth: a cross country comparison. Tob Control (2002) 5.58
Text and graphic warnings on cigarette packages: findings from the international tobacco control four country study. Am J Prev Med (2007) 5.05
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med (2009) 4.90
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med (2007) 4.49
Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41
Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health (2002) 4.22
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA (2011) 4.09
Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis (2008) 4.09
Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax (2006) 4.04
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax (2003) 4.02
Usage and longitudinal effectiveness of a Web-based self-help cognitive behavioral therapy program for panic disorder. J Med Internet Res (2005) 3.81
Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ (2002) 3.78
Developing COPD: a 25 year follow up study of the general population. Thorax (2006) 3.72
Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care (2013) 3.65
Quality of private and public ambulatory health care in low and middle income countries: systematic review of comparative studies. PLoS Med (2011) 3.60
Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis. J Gen Intern Med (2007) 3.49
Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med (2009) 3.41
Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science (2003) 3.34
Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet (2007) 3.22
Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A (1998) 3.22
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One (2011) 3.21
Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A (2001) 3.01
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet (2007) 2.93
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Patient adherence in COPD. Thorax (2008) 2.85
Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax (2004) 2.85
Reed-Elsevier's hypocrisy in selling arms and health. J R Soc Med (2007) 2.82
Teaching medical students about tobacco. Thorax (1999) 2.81
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
Use of health care services by people with mental illness: secondary data from three statutory health insurers and the German Statutory Pension Insurance Scheme. Dtsch Arztebl Int (2013) 2.64
Should depression be managed as a chronic disease? BMJ (2001) 2.63
Pulmonary rehabilitation. Thorax (2001) 2.63
Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards. Popul Health Metr (2011) 2.62
Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health (2009) 2.59
A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health (2000) 2.49
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax (2006) 2.46
Depression and cardiovascular disease: healing the broken-hearted. JAMA (2006) 2.44
COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest (2010) 2.40
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax (2006) 2.38
Improvement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort study. BMJ (2005) 2.36
A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract (2005) 2.31
Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer (2004) 2.31
Education level inequalities and transportation injury mortality in the middle aged and elderly in European settings. Inj Prev (2005) 2.25
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25
Comparative risk assessment of the burden of disease from climate change. Environ Health Perspect (2006) 2.19
Effectiveness of speed cameras in preventing road traffic collisions and related casualties: systematic review. BMJ (2005) 2.19
Academic health center management of chronic diseases through knowledge networks: Project ECHO. Acad Med (2007) 2.18
Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax (2013) 2.13
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest (2007) 2.12
Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med (2010) 2.12
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax (2007) 2.05
Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health (2005) 2.04
Molecular pathogenesis of emphysema. J Clin Invest (2008) 2.03
The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran. Arch Iran Med (2013) 2.01
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Global childhood unintentional injury surveillance in four cities in developing countries: a pilot study. Bull World Health Organ (2009) 2.00
Performance-based measures of functional skills: usefulness in clinical treatment studies. Schizophr Bull (2007) 2.00
Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect Immun (2006) 1.99
The global burden of mental disorders. Am J Public Health (1999) 1.97
Epidemiology of violent deaths in the world. Inj Prev (2001) 1.96
Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol (2010) 1.96
Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ (2010) 1.95
Developing a comprehensive time series of GDP per capita for 210 countries from 1950 to 2015. Popul Health Metr (2012) 1.95
Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax (2007) 1.92
Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med (2013) 1.92
Concern c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am J Respir Crit Care Med (2011) 1.91
Stigmatization of people with mental illnesses: a follow-up study within the Changing Minds campaign of the Royal College of Psychiatrists. World Psychiatry (2005) 1.91
Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med (2006) 1.88
Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis (2012) 1.87
Self-monitoring using mobile phones in the early stages of adolescent depression: randomized controlled trial. J Med Internet Res (2012) 1.86
Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis (2009) 1.85
Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health (2005) 1.85
Traffic calming for the prevention of road traffic injuries: systematic review and meta-analysis. Inj Prev (2003) 1.85
Applying insights from biofilm biology to drug development - can a new approach be developed? Nat Rev Drug Discov (2013) 1.82
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci U S A (2002) 1.81
Adapting group interpersonal psychotherapy for a developing country: experience in rural Uganda. World Psychiatry (2003) 1.77
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax (2006) 1.76
Effect of recall on estimation of non-fatal injury rates: a community based study in Tanzania. Inj Prev (2005) 1.75
Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci U S A (2009) 1.74
Is depression overdiagnosed? No. BMJ (2007) 1.74
Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health (2012) 1.74
Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2008) 1.73
Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry (2008) 1.73
Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med (2007) 1.70
Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70
Construction and characterization of a Mycobacterium tuberculosis mutant lacking the alternate sigma factor gene, sigF. Infect Immun (2000) 1.68
Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67
The MacNew Heart Disease health-related quality of life instrument: a summary. Health Qual Life Outcomes (2004) 1.66
Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax (2003) 1.66
Increasing access to surgical services in sub-saharan Africa: priorities for national and international agencies recommended by the Bellagio Essential Surgery Group. PLoS Med (2009) 1.66
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94
Armed conflict as a public health problem. BMJ (2002) 4.42
Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31
On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66
The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46
Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37
Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17
The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84
The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49
Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12
Measuring the burden of disease. Lancet (1998) 1.58
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Hypertension in developing countries. World Health Stat Q (1988) 1.45
Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35
Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33
Tobacco or health. World Health Stat Q (1993) 1.32
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19
Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
On the assessment of maternal mortality. World Health Stat Q (1987) 1.04
A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02
Sex differentials in mortality. WHO Chron (1984) 1.02
Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00
Reducing child mortality. Bull World Health Organ (2000) 0.94
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92
Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91
Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89
Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88
Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86
Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85
Smoking and death in Russia. Tob Control (1998) 0.84
Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83
A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83
The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81
Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81
Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80
Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80
100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79
Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79
Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78
Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78
Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78
Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77
Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77
Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76
In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76
Investigating Australia's burden of disease. Med J Aust (2000) 0.75
Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75
Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75
Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75
Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75
The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75
Health projections. Introduction. World Health Stat Q (1984) 0.75
Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75
[Preventable deaths: general view]. World Health Stat Q (1989) 0.75